Top Medicine is a professional and leading manufacturer and supplier of active pharmaceutical ingredients and pharmaceutical intermediates. Our objective is to sharpen our edge of fine pharmaceutical chemistry and supply quality chemical materials and valuable services to meet customers’immediate needs by facilitating their further synthesis to an extent where there is substantial output with less input and higher yield. Taking innovation and quality assurance as daily life and core activity, we concentrate on building up a modern, safe and environment-friendly workplace and creating an efficient way of generating mutual benefits. All customers and end-users are encouraged to reach us in an open way and our technical people are ready to work together with your technical staff to tackle technical problems you have. Meanwhile we appreciate joint efforts to making improvements in quality and business relationship with honest and sincere agents or distributors who value business as much as service and technical support. We firmly believe our service will satisfy your immediate needs of production and economy.
Top Medicine has made its own formula for success by focusing on its pharmaceutical intermediates sector which is the strongest among main business activities. D-Dihydrophenylglycine Sodium Dane Salt, side chain for Cefradine, enjoys the largest capacity in China, and good consistency in quality and service with the yearly capacity up to 1,000 tons and a 40% market share in China. SIN-methoxyimno-furanyl-acetic acid ammonium salt (SMIA) is a side chain of Cefuroxime. (S)-pyrrolidine-2-carboxamide and 1-amino-3-hydroxyadamantane, key intermediates for Vildagliptin, are leading spikes and new economic growth potentials. Calcium Polycarbophil, an API for chronic constipation and watery diarrhea, enjoys substantial market shares in USA, EU countries, Japan and South Korea. Some new applications and leading spikes are under development now.
Quality Assurance
All APIs are produced under global GMP guidelines and meet international standards and regulations. All substances and products are tested according to regulatory pharmacopieas, validated analytical methods and Quality Agreement with Customers. Amoxicillin workshop passed GMP inspection in 2004. DMF of Calcium Polycarbophil was submitted to US FDA (DMF Ref. No. 20251) in January 2007. Calcium Polycarbophil got Japan GMP approval in January 2009. Top is now living up to its commitments of manufacturing in accordance with presented dossier and cGMP practice in Calcium Polycarbophil production activities.
Products
Enterprise data throughAuthenticate
E-mail: